Category: Medical Devices
-
![(ATHA.Q), (BIIB.Q), (SAVA.Q), (DRAD.Q), (SUPN.Q), (XLV.NYSE): Trump or Biden? Canadians freak out, healthcare stocks go ballistic]()
(ATHA.Q), (BIIB.Q), (SAVA.Q), (DRAD.Q), (SUPN.Q), (XLV.NYSE): Trump or Biden? Canadians freak out, healthcare stocks go ballistic
Sick democracy – sick people – big profits. That was a cogitative jump that most investors seemed to make.
-
Perimeter Medical Imaging AI (PINK.V) isn’t messing about: Let’s make breast cancer treatment better – and profitable!
In the North American biotech space, you hear a lot of ‘promise’ from companies and their teams. Lots of ‘we’re going to take this to trial’, and a lot of ‘billion dollar industry’ talk. Lots of early stage bets, a little over-hype perhaps. For the most part, you’re being asked to invest in technologies that…
-
Perimeter Medical Imaging AI (PINK.V) shuffles the deck
PINK is accelerating toward the commercialisation of the OTIS platform. It has already received a $7.4 million grant (non-dilutive capital) from the Cancer Prevention and Research Institute of Texas (CPRIT) to fund the ATLAS AI Project.
-
Perimeter Medical Imaging AI (PINK.V) untapped value in medtech
Investing your money in health or medical companies is difficult. The complexity of the science often deters investors from allocating a portion of their portfolio to said industry, despite those companies having proven potential to provide the largest gains for its investors. We’re not criticizing – everyone knows that medical terminology is only second to…
-
![Plurilock Technologies: Disrupting Biometric Cybersecurity]()
Plurilock Technologies: Disrupting Biometric Cybersecurity
The new economy is digital. It’s in the trillions, so increasing digitization of the world has led to an increased risk that some parts of the ecosystem will be compromised. It’s no surprise then, that a ton of cybersecurity firms have emerged and attempted to dominate the landscape of ensuring and maintaining data privacy. However,…
-
Perimeter Medical Imaging AI: Covering the Margin Calls for Cancer
For the last eight months, the Covid-19 virus has been the centre of attention in the media, the markets, and the medical field. Collectively, countries, government agencies, academic institutions and pharmaceutical companies across the world have poured hundreds of millions into efforts combating the viral outbreak that has left so many countries and populations struggling…
-
Perimeter Medical Imaging AI (PINK.V): They’re not curing cancer here, but they’ll help dig it out..
For the last eight months, the Covid-19 virus has been the center of attention in the media, the markets, and the medical field. Collectively, countries and government agencies, and academia, and pharmaceutical companies, have poured hundreds of millions into efforts combating the plague that has left so many countries and populations struggling, but despite the…
-
![PredictMedix: Pharma Monopoly Meets Tech Growth]()
PredictMedix: Pharma Monopoly Meets Tech Growth
Here’s a simple and effective investment strategy: invest in companies that sell products with growing inelastic demand.
-
![2020 Gravitas Securities Growth Conference lines up seriously interesting deals, even in weed]()
2020 Gravitas Securities Growth Conference lines up seriously interesting deals, even in weed
Respect where it’s due, I haven’t been to an investor conference in a long time where I came away interested in most of what I saw, let alone *everything* I saw, but this year’s Gravitas Securities Growth Conference lineup absolutely hit it out of the park. The GSGC isn’t the biggest show around, but they…
-
Three non-weed deals you don’t know: ParcelPal (PKG.C), Clear Blue (CBLU.V), and Titan Medical (TMD.T)
If I was getting paid by the number of pitches I hear, I’d be making a lot more money than I do. Often, they’re terrible. And I include ‘just okay’ in the terrible column, because if your investment pitch isn’t lights out amazing, it’s death. Sometimes I hear pitches that I really love, but the…
